New drugs enabled by artificial intelligence

At first glance, biology and computer science seem like opposites.
In reality, however, computer science is something like a highly
organized manager for modern biology: wherever enormous amounts of
data are generated from research, progress is hardly possible
without digital methods. Bioinformatician Prof. Andreas Keller
therefore relies on artificial intelligence. He heads the Clinical
Bioinformatics research group at the Helmholtz Institute for
Pharmaceutical Research Saarland, or HIPS for short – an institute
founded in 2009 by the Helmholtz Centre for Infection Research and
Saarland University. In this episode of InFact, host Julia Demann
talks to him about how AI can help us understand how beneficial and
harmful bacteria communicate with each other in our bodies, how to
predict when infections will cause long-term effects, and how this
can be used to develop new drugs against dangerous pathogens.